Keywords
Treatment
Quality of life
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To compare the quality of life of adults with T1DM treated with CSII and MDI, and to analyze sociodemographic aspects, self-reported glycemic control, and perceptions regarding the therapeutic method. Methods: A total of 308 participants with T1DM, aged between 18 and 59 years, were included. They completed an online questionnaire covering sociodemographic conditions and quality of life assessment (WHOQOL-Bref). Proportions were compared using the chi-square test (χ²) and Fisher's exact test, while numerical variables between groups were compared using Student's t-test or the Mann-Whitney U test (p<0.05). Results: Overall, 54.2% of participants used MDI and 45.8% used CSII, with a mean age of 31 ± 9.1 years. Participants in the CSII group had higher income. Regarding the self-reported frequency of hyperglycemia and hypoglycemia, similar results were found in both groups. The CSII group showed higher self-rated quality of life, with no significant differences in the other WHOQOL-Bref domains. Most MDI users expressed a desire to switch methods, unlike the CSII group. Conclusion: CSII users showed higher self-rated quality of life scores compared to the MDI group, although no significant differences were observed between the groups in the remaining WHOQOL-Bref domains.
References
ARRUDA GO, et al. Intervenção educativa em homens com diabetes mellitus: efeitos sobre comportamentos e perfil antropométrico. Acta Paul Enferm, 2020; 33: 1-10.
ANDRADE RGS, et al. Processos judiciais para aquisição de bomba de insulina em Ribeirão Preto. Revista Bioética Print, 2018; 26(1): 102-108.
BARRAUD S. Severity of complications is associated with impaired health-related quality of life in people with type 1 diabetes. Diabetes Obes Metab, 2026; 28(2):1201-1212.
BORGES DE VASCONCELOS L, et al. Qualidade de vida relacionada à saúde: análise dimensional do conceito. Novas tendências em pesquisa qualitativa, 2020; 3: 226–238.
BRANDÃO GL, et al. Análise de percepção da insulinoterapia em diabéticos tipo 1 no Serviço de Apoio e Assistência aos Diabéticos e seus Familiares. Revista da Sociedade Brasileira de Clínica Médica, 2020; 18(2):104-7.
BRIGANTI SI, et al. Impact of technologies on quality of life in relation to glucose control in patients with type 1 diabetes. J Diabetes Complications, 2025; 40: 109215.
CAMPBELL F, et al. Follow-Up Support for Effective type 1 Diabetes self-management (The FUSED Model): A systematic review and meta-ethnography of the barriers, facilitators and recommendations for sustaining self-management skills after attending a structured education programme. BMC Health Serv Res, 2018; 18(1): 898.
CALDERON MARTINEZ E, et al. Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections for Glycemic Control in Pediatric Patients With Type 1 Diabetes Mellitus: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis. AACE Endocrinol Diabetes. 2025; 13(2):242-252.
CAPPON G, et al. A. Continuous Glucose Monitoring Sensors for Diabetes Management: A Review of Technologies and Applications, 2019; 43(4):383-397.
CARLSON AL, et al. The Role, Potential Benefits and Cost-effectiveness of Digital Tools for Diabetes Management. Clin Ther, 2025; 47(8):638-648.
CARNEIRO VS, et al. Saúde do homem: identificação e análise de fatores relacionados à procura, ou não, dos serviços de atenção primária. Arq. Cienc. Saúde UNIPAR, 2019; 23(1): 35-40.
CASTRO ARV, et al. Custo do tratamento do diabetes mellitus tipo 1: dificuldades das famílias. Acta paul enferm, 2019; 21(4): 624-628.
COMMISSARIAT PV, et al. Insulin pump use in young children with type 1 diabetes: sociodemographic factors and parent-reported barriers. Diabetes technology & therapeutics, 2017; 19 (6): 363-369.
DE OLIVEIRA COUTINHO C, et al. Gênero e necessidades de saúde dos homens: o cuidado na perspectiva de profissionais de saúde. Saúde em Debate, 2026; 50(149): 1-14.
DE ALBUQUERQUE EZ, et al. Contagem de carboidratos, estado nutricional e perfil metabólico em adolescentes com diabetes mellitus tipo 1. Scientia Medica, 2014; 24(4):343-352.
DE FREITAS PS, et al. Perfil e qualidade de vida de pacientes com Diabetes mellitus tipo 1 tratados com insulina convencional. Revista Strictu Sensu, 2022; 7(1): 38-57.
GOMES MB, et al. Type 1 diabetes in Brazil: a narrative overview of the Brazilian Type 1 Diabetes Study Group. Diabetol Metab Syndr. 2025; 17(1): 166.
GOMES R, et al. Por que os homens buscam menos os serviços de saúde do que as mulheres? As explicações de homens com baixa escolaridade e homens com ensino superior. Cad saúde pública. 2007; 23(3):565-74.
HAUGHTON S, et al. The impact of insulin pump therapy compared to multiple daily injections on complications and mortality in type 1 diabetes: A real-world retrospective cohort study. Diabetes Obes Metab, 2025; 27(8):4239-4247.
KARGES B, et al. Association of insulin pump therapy vs insulin injection therapy with severe hypoglycemia, ketoacidosis, and glycemic control among children, adolescents, and young adults with type 1 diabetes. JAMA, 2017; 318(14):1358-1366.
KAPELLEN TM, et al. Indications for insulin pump therapy in different age groups—an analysis of 1567 children and adolescents. Diabetic medicine, 2007; 24(8): 836-842.
KLUTHCOVSKY ACGC, et al. O WHOQOL- bref, instrumento para avaliar qualidade de vida: uma revisão sistemática. Rev. psiquiatr. Rio Gd. Sul, 2009; 31(3): 1-12.
KRAUSE M, et al. Type 1 and Type 2 Diabetes Mellitus: Commonalities, Differences and the Importance of Exercise and Nutrition. Nutrients, 2023; 15(19): 4279.
LU JC, et al. Meal-time glycaemia in adults with type 1 diabetes using multiple daily injections vs insulin pump therapy following carbohydrate-counting education and bolus calculator provision. Diabetes Res Clin Pract, 2021; 179: 109000.
MCCLURE RD, et al. Exploring Technology's Influence on Health Behaviours and Well-being in Type 1 Diabetes: a Review. Curr Diab Rep, 2024; 24(4):61-73.
MESBAH NI, et al. Experiences of adults using continuous subcutaneous insulin infusion: a qualitative study. Med Princi Pract, 2020; 29(3): 255-261.
MÜLLER VM, et al. Diabetes tipo 1 e suas principais complicações. Revista Eletrônica Acervo Saúde, 2024; 24(1): e14646.
NEVES RG, et al. Complicações por diabetes mellitus no Brasil: estudo de base nacional, 2019. Ciênc. Saúde Colet., 2023; 28: 3183-3190.
NIMRI R, et al. Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes. Nature medicine, 2020; 26: 1380-1384.
PICKUP JC. Is insulin pump therapy effective in Type 1 diabetes? Diabet Med. 2019, 6(3):269-278.
RAMALHO ELR, et al. Clinical and sociodemographic factors associated with the quality of life of children and adolescents with type 1 diabetes. Revista da Escola de Enfermagem da USP, 2023; 57: e20230195.
RIBEIRO ME, et al. Insulinoterapia contínua versus múltiplas injeções de insulina no tratamento da diabetes tipo 1: um estudo longitudinal. Rev Paul Pediatr, 2016; 34(1): 86-90.
SALES-PERES SHC, et al. Estilo de vida em pacientes portadores de diabetes mellitus tipo 1: uma revisão sistemática. Ciênc. saúde colet., 2016; 21 (4): 1197-1206.
SILLER AF, et al. Challenges in the diagnosis of diabetes type in pediatrics. Pediatr Diabetes. 2020; 21 (7): 1064-1073.
SILVA C, et al. Percepção dos usuários de bomba de infusão de insulina no sudeste Goiano. HOLOS, 2017; 5: 186-196.
SILVEIRA D, et al. Infusão subcutânea contínua de insulina: cenário nacional e internacional. Cad. saúde colet., 2016; 24: 496-501.
SOUSA MC, et al. Correlation of quality of life with knowledge and attitude of diabetic elderly. Invest. educ. Enferm. 2016, 34(1): 180-8.
TZIVIAN L, et al. Quantitative and qualitative analysis of the quality of life of Type 1 diabetes patients using insulin pumps and of those receiving multiple daily insulin injections. Health Qual Life Outcomes, 2022. 20 (1): 120.
ZIEGLER AG, et al. The future of type 1 diabetes therapy. Lancet, 2025; 406(10511):1520-1534.